Effectiveness of COVID-19 primary and booster vaccination in HIV-infected individuals

AIDS. 2023 Apr 1;37(5):837-839. doi: 10.1097/QAD.0000000000003492.

Authors

Bin Su¹, Guido Vanham²

Affiliations

¹ Beijing Key Laboratory for HIV/AIDS Research, Sino-French Joint Laboratory for Research on Humoral Immune Response to HIV Infection, Clinical and Research Center for Infectious Diseases, Beijing Youan Hospital, Capital Medical University, Beijing, China.
² Global Health Institute, University of Antwerp, Campus Drie Eiken, Gouverneur Kinsbergencentrum, Wilrijk, Belgium.

PMID: 36919787
DOI: 10.1097/QAD.0000000000003492

No abstract available

Publication types

Editorial
Research Support, Non-U.S. Gov't
Comment

MeSH terms

COVID-19* / prevention & control
HIV Infections* / complications
HIV Infections* / prevention & control
Humans
Vaccination